BACKGROUND AND PURPOSE: The purpose of this prospective study was to evaluate the hypothesis that magnetization transfer ratio (MTR) histogram analysis of the whole brain could detect early and subtle brain changes nonapparent on conventional magnetic resonance imaging (MRI) in children with acute lymphoblastic leukemia (ALL) receiving methotrexate (MTX) therapy. MATERIALS AND METHODS: Subjects in this prospective study comprised 10 children with ALL (mean age, 6 years; range, 0-16 years). In addition to conventional MRI, magnetization transfer images were obtained before and after intrathecal and intravenous MTX therapy. MTR values were calculated and plotted as a histogram, and peak height and location were calculated. Differences in peak height and location between pre- and post-MTX therapy scans were statistically analyzed. Conventional MRI was evaluated for abnormal signal area in white matter. RESULTS: MTR peak height was significantly lower on post-MTX therapy scans than on pre-MTX therapy scans (p = 0.002). No significant differences in peak location were identified between pre- and post-chemotherapy imaging. No abnormal signals were noted in white matter on either pre- or post-MTX therapy conventional MRI. CONCLUSIONS: This study demonstrates that MTR histogram analysis allows better detection of early and subtle brain changes in ALL patients who receive MTX therapy than conventional MRI.
BACKGROUND AND PURPOSE: The purpose of this prospective study was to evaluate the hypothesis that magnetization transfer ratio (MTR) histogram analysis of the whole brain could detect early and subtle brain changes nonapparent on conventional magnetic resonance imaging (MRI) in children with acute lymphoblastic leukemia (ALL) receiving methotrexate (MTX) therapy. MATERIALS AND METHODS: Subjects in this prospective study comprised 10 children with ALL (mean age, 6 years; range, 0-16 years). In addition to conventional MRI, magnetization transfer images were obtained before and after intrathecal and intravenous MTX therapy. MTR values were calculated and plotted as a histogram, and peak height and location were calculated. Differences in peak height and location between pre- and post-MTX therapy scans were statistically analyzed. Conventional MRI was evaluated for abnormal signal area in white matter. RESULTS: MTR peak height was significantly lower on post-MTX therapy scans than on pre-MTX therapy scans (p = 0.002). No significant differences in peak location were identified between pre- and post-chemotherapy imaging. No abnormal signals were noted in white matter on either pre- or post-MTX therapy conventional MRI. CONCLUSIONS: This study demonstrates that MTR histogram analysis allows better detection of early and subtle brain changes in ALL patients who receive MTX therapy than conventional MRI.
Authors: Charles B Stevenson; Moneeb Ehtesham; Kathryn M McMillan; J Gerardo Valadez; Michael L Edgeworth; Ronald R Price; Ty W Abel; Khubaib Y Mapara; Reid C Thompson Journal: Neurosurgery Date: 2008-09 Impact factor: 4.654
Authors: Ellen van der Plas; Brian J Nieman; Darci T Butcher; Johann K Hitzler; Rosanna Weksberg; Shinya Ito; Russell Schachar Journal: J Can Acad Child Adolesc Psychiatry Date: 2015-03-04
Authors: Shelli R Kesler; Charlotte Sleurs; Brenna C McDonald; Sabine Deprez; Ellen van der Plas; Brian J Nieman Journal: J Clin Oncol Date: 2021-04-22 Impact factor: 50.717
Authors: Abimbola A Akintola; Annette van den Berg; Irmhild Altmann-Schneider; Steffy W Jansen; Mark A van Buchem; P Eline Slagboom; Rudi G Westendorp; Diana van Heemst; Jeroen van der Grond Journal: Age (Dordr) Date: 2015-07-17
Authors: Michiel Sala; Albert de Roos; Gerard J Blauw; Huub A M Middelkoop; J Wouter Jukema; Simon P Mooijaart; Mark A van Buchem; Anton J M de Craen; Jeroen van der Grond Journal: BMC Neurol Date: 2015-08-07 Impact factor: 2.474